Abstract
ABSTRACT Multiple Sclerosis (MS) is a chronic autoimmune disease that causes demyelination in the central nervous system, leading to significant physical and cognitive impairments. Depression is a common comorbidity in MS patients, further complicating their treatment and negatively affecting their quality of life. This study aimed to examine the impact of comorbid depression on medication adherence and clinical outcomes in MS patients, emphasizing the need for integrated psychiatric care. A detailed evaluation was conducted on an MS patient presenting symptoms of depression. This included a full psychiatric assessment, laboratory tests to rule out other medical conditions, and neuroimaging to confirm the MS diagnosis. The patient showed severe symptoms of depression, including psychomotor retardation, weight loss, and sleep disturbances. After starting treatment with escitalopram, the patient showed significant improvement in depressive symptoms within one month, highlighting the effectiveness of tailored psychiatric interventions in managing depression in MS patients.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call